Goldman Sachs
EUCR

Goldman Sachs’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Goldman Sachs’s Portfolio EUCR Stock Details EUCR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$307K Sell
2022
Q2 		$550K Sell
2022
Q1 		$5.45M Buy
2021
Q4 		$343K Sell
2021
Q3 		$364K Buy
2021
Q2 		$109K Buy